Search for other papers by Amin Khoshbayan in
Current site
Google Scholar
PubMed
Search for other papers by Aref Shariati in
Current site
Google Scholar
PubMed
Search for other papers by Shabnam Razavi in
Current site
Google Scholar
PubMed
Search for other papers by Zohre Baseri in
Current site
Google Scholar
PubMed
Search for other papers by Arash Ghodousi in
Current site
Google Scholar
PubMed
Search for other papers by Davood Darban-Sarokhalil in
Current site
Google Scholar
PubMed
Abstract
Colistin is considered as one of a last resort antimicrobial agent against multidrug-resistant Gram-negative bacteria including Escherichia coli and Klebsiella pneumoniae. However, the recent emergence of colistin resistance (ColR) worldwide that severely restricts therapeutic options is a serious threat to global public health. In this study we have investigated the molecular determinants in ColR K. pneumoniae isolates collected from clinical specimens.
A total of 98 E. coli and 195 K. pneumoniae clinical isolates were collected from two hospitals from August 2018 to December 2019 in Tehran, Iran. Colistin susceptibility and minimum inhibitory concentrations (MIC) were determined according to the Clinical and Laboratory Standards Institute by disk diffusion method, and microdilution method, respectively. For isolates with colistin MIC ≥4 μg mL−1, PCR was performed for the detection of mcr-1 to mcr-4 genes. Moreover, nucleotide sequences of mgrB, phoP, phoQ, pmrA, and pmrB genes were determined by sequencing. Finally, the transcriptional level of pmrK and pmrC genes was evaluated by quantitative reverse transcription PCR (RT-qPCR).
None of the E. coli isolates were resistant to colistin while 21 out 195 K. pneumoniae isolates were identified as resistant, 19 of which carried mutation in the mgrB gene. Three different mutations were observed in the pmrB gene in 3 K. pneumoniae isolates. None of the ColR isolates showed alternations in pmrA, phoP, and phoQ genes. Furthermore, none of the plasmid-encoding genes were detected. Transcriptional level of the pmrK gene increased in all ColR isolates meanwhile, pmrC overexpression was detected in 16 out 21 (76.19%) isolates. Eventually, all ColR isolates were susceptible to tigecycline. Our results demonstrated that the alternation of mgrB gene is the main mechanism related to colistin resistance among ColR K. pneumoniae isolates in this study.
-
1.
Falagas ME , Maraki S , Karageorgopoulos DE , Kastoris AC , Mavromanolakis E , Samonis G . Antimicrobial susceptibility of Multidrug-Resistant (MDR) and extensively Drug-Resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents 2010;35:240–243.
-
2.
Boucher HW , Talbot GH , Bradley JS , Edwards JE , Gilbert D , Rice LB , et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1–12.
-
3.
Jayol A , Poirel L , Brink A , Villegas M-V , Yilmaz M , Nordmann P . Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 2014;58:4762–4766.
-
4.
Haeili M , Kafshdouz M , Feizabadi MM . Molecular mechanisms of colistin resistance among pandrug-resistant isolates of Acinetobacter baumannii with high case-fatality rate in intensive care unit patients. Microbl Drug Resist 2018;24:1271–1276.
-
5.
Marinelli F , Genilloud O . Antimicrobials: new and old molecules in the fight against multi-resistant bacteria. Springer Science & Business Media; 2013.
-
6.
Novović K , Trudić A , Brkić S , Vasiljević Z , Kojić M , Medić D , et al. Molecular epidemiology of colistin-resistant, carbapenemase-producing Klebsiella pneumoniae in Serbia from 2013 to 2016. Antimicrob Agents Chemother 2017;61(5):e02550–e02616.
-
7.
Liu Y-Y , Wang Y , Walsh TR , Yi L-X , Zhang R , Spencer J , et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161–168.
-
8.
Li J , Nation RL , Turnidge JD , Milne RW , Coulthard K , Rayner CR , et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006;6:589–601.
-
9.
Pishnian Z , Haeili M , Feizi A . Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran. Gut Pathog 2019;11:1–8.
-
10.
Poirel L , Jayol A , Bontron S , Villegas M-V , Ozdamar M , Türkoglu S , et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 2015;70:75–80.
-
11.
Cheng Y-H , Lin T-L , Lin Y-T , Wang J-T . Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae. Antimicrob Agents Chemother 2016;60:3709–3716.
-
12.
Haeili M , Javani A , Moradi J , Jafari Z , Feizabadi MM , Babaei E . MgrB alterations mediate colistin resistance in Klebsiella pneumoniae isolates from Iran. Front Microbiol 2017;8:2470.
-
13.
Olaitan AO , Morand S , Rolain J-M . Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 2014;5:643.
-
14.
Cannatelli A , Giani T , D’Andrea MM , Di Pilato V , Arena F , Conte V , et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 2014;58:5696–5703.
-
15.
Olaitan AO , Diene SM , Kempf M , Berrazeg M , Bakour S , Gupta SK , et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 2014;44:500–507.
-
16.
Yin W , Li H , Shen Y , Liu Z , Wang S , Shen Z , et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio 2017;8.
-
17.
Xavier BB , Lammens C , Ruhal R , Kumar-Singh S , Butaye P , Goossens H , et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill 2016;21:30280.
-
18.
Carattoli A , Villa L , Feudi C , Curcio L , Orsini S , Luppi A , et al. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill 2017;22:30589.
-
19.
Moosavian M , Emam N . The first report of emerging mobilized colistin-resistance (mcr) genes and ERIC-PCR typing in Escherichia coli and Klebsiella pneumoniae clinical isolates in southwest Iran. Infect Drug Resist 2019;12:1001.
-
20.
Tille P . Bailey & Scott’s diagnostic microbiology-e-book. Elsevier Health Sciences; 2015.
-
21.
Schippa S , Iebba V , Barbato M , Di Nardo G , Totino V , Checchi MP , et al. A distinctive’microbial signature’in celiac pediatric patients. BMC Microbiol 2010;10:175.
-
22.
Clinical and Laboratory Standards Institute . Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
-
23.
Magiorakos A-P , Srinivasan A , Carey R , Carmeli Y , Falagas M , Giske C , et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–281.
-
24.
Khoshbayan A , Shariati A , Shahmoradi S , Baseri Z , Mozafari H , Darban-Sarokhalil D . Prevalence and molecular mechanisms of colistin resistance in Acinetobacter baumannii clinical isolates in Tehran, Iran. Acta Microbiol Immunol Hung 2021;68:262–266.
-
25.
Wiegand I , Hilpert K , Hancock RE . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008;3:163.
-
26.
Asadollahi P , Akbari M , Soroush S , Taherikalani M , Asadollahi K , Sayehmiri K , et al. Antibiotic resistance patterns among Acinetobacter baumannii strains isolated from burned patients. 2012;38:1198–1203.
-
27.
Kim SY , Choi HJ , Ko KS . Differential expression of two-component systems, pmrAB and phoPQ, with different growth phases of Klebsiella pneumoniae in the presence or absence of colistin. Curr Microbiol 2014;69:37–41.
-
28.
Schmittgen TD , Livak KJ . Analyzing real-time PCR data by the comparative C T method. Nat Protoc 2008;3:1101.
-
29.
Livak KJ , Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 2001;25:402–408.
-
30.
Cannatelli A , D’Andrea MM , Giani T , Di Pilato V , Arena F , Ambretti S , et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 2013;57:5521–5526.
-
31.
Morrill HJ , Pogue JM , Kaye KS , LaPlante KL . Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect Dis 2015; 2(2):ofv050.
-
32.
Nordmann P , Dortet L , Poirel L . Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012;18:263–272.
-
33.
Velkov T , Thompson PE , Nation RL , Li J . Structure− activity relationships of polymyxin antibiotics. J Med Chem 2010;53:1898–1916.
-
34.
Sharahi JY , Hashemi A , Ardebili A , Davoudabadi S . Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran. Ann Clin Microbiol Antimicrob 2021;20:32.
-
35.
Bolourchi N , Shahcheraghi F , Giske CG , Nematzadeh S , Noori Goodarzi N , Solgi H , et al. Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals. Ann Clin Microbiol Antimicrob 2021;20:74.
-
36.
Solgi H , Shahcheraghi F , Bolourchi N , Ahmadi A . Molecular characterization of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae ST11 harbouring blaNDM-1 and blaOXA-48 carbapenemases in Iran. Microb Pathog 2020;149:104507.
-
37.
Cheng Y-H , Lin T-L , Pan Y-J , Wang Y-P , Lin Y-T , Wang J-T . Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan. Antimicrob Agents Chemother 2015;59:2909–2913.
-
38.
Aires CAM , Pereira PS , Asensi MD , Carvalho-Assef APDA . mgrB mutations mediating polymyxin B resistance in Klebsiella pneumoniae isolates from rectal surveillance swabs in Brazil. Antimicrob Agents Chemother 2016;60:6969–6972.
-
39.
Bogdanovich T , Adams-Haduch JM , Tian G-B , Nguyen MH , Kwak EJ , Muto CA , et al. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)–producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 2011;53:373–376.
-
40.
Zarkotou O , Pournaras S , Voulgari E , Chrysos G , Prekates A , Voutsinas D , et al. Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. J Clin Microbiol 2010;48:2271–2274.
-
41.
Humphries RM , Kelesidis T , Bard JD , Ward KW , Bhattacharya D , Lewinski MA . Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol 2010;59:1383–1386.
-
42.
Kontopoulou K , Protonotariou E , Vasilakos K , Kriti M , Koteli A , Antoniadou E , et al. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistin. J Hosp Infect 2010;76:70–73.
-
43.
Antoniadou A , Kontopidou F , Poulakou G , Koratzanis E , Galani I , Papadomichelakis E , et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother 2007;59:786–790.
Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary
Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- Chemical Abstracts
- Global Health
- Index Medicus
- Index Veterinarius
- Medline
- Referativnyi Zhurnal
- SCOPUS
- Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 1.3 |
| Rank by Impact Factor | Q4 (Immunology) |
| Journal Citation Indicator | 0.31 |
| Scopus | |
| CiteScore | 2.3 |
| CiteScore rank | Q3 (Infectious Diseases) |
| SNIP | 0.389 |
| Scimago | |
| SJR index | 0.308 |
| SJR Q rank | Q3 |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article (only for OA publications) |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 772 EUR / 848 USD Print + online subscription: 860 EUR / 944 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
1954 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 1217-8950 (Print) |
| ISSN | 1588-2640 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Apr 2024 | 41 | 1 | 1 |
| May 2024 | 40 | 0 | 0 |
| Jun 2024 | 47 | 0 | 1 |
| Jul 2024 | 23 | 0 | 0 |
| Aug 2024 | 83 | 0 | 0 |
| Sep 2024 | 58 | 0 | 0 |
| Oct 2024 | 14 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.